A phase III, randomized, controlled trial of the fully human IL-12/23 mAb briakinumab in moderate-to-severe psoriasis

Kenneth B. Gordon, Richard G. Langley, Alice B. Gottlieb, Kim A. Papp, Gerald G. Krueger, Bruce E. Strober, David A. Williams, Yihua Gu, Joaquin M. Valdes

Research output: Contribution to journalArticlepeer-review

147 Scopus citations

Fingerprint

Dive into the research topics of 'A phase III, randomized, controlled trial of the fully human IL-12/23 mAb briakinumab in moderate-to-severe psoriasis'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science